Corteva, Inc. CTVA

78.52 (0.93) (1.17%) as of 25 Sep
Market cap
$53.0B
P/E
52.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Insider Decisions

Total sells 0.64
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — 1 — — — — — — —
Insider Ownership 0.36%

Capital & Financial Ratios

Market Cap 53,010.00
Revenue 17,812.00
Net Income 1,021.00
Free Cash Flow 659.00
Net Debt 2,510.00
Current Ratio 1.52
Debt/Equity 0.19
P/E ratio 52.00
P/S ratio 2.95
P/B ratio 2.07
Past 5Y EPS Growth (15.45%)
This Y EPS Growth 12.85%
Next Y EPS Growth 10.07%
Next 5Y EPS Growth 11.25%
in millions of $

Dividends

Payout Ratio 0.38
Annual Dividend Rate 0.64
Annual Dividend Yield 1.31%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 0.74
0.18
0.18
0.18
2025 0.70
0.17
0.17
0.18
0.18
2024 0.66
0.16
0.16
0.17
0.17
2023 0.62
0.15
0.15
0.16
0.16
2022 0.58
0.14
0.14
0.15
0.15
2021 0.54
0.13
0.13
0.14
0.14
2020 0.52
0.13
0.13
0.13
0.13
2019 0.26
0.13
0.13
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 2,742 3,169 4,530 2,365
Receivables 5,488 5,676 6,371 8,696
Inventory 6,899 5,432 5,667 4,443
Other 1,131 820 767 853
16,260 15,097 17,335 16,357
2023 2024 2025 Q'26
Payables 4,280 4,039 4,398 3,958
ST’ Debt 198 750 894 3,193
Other — — — —
10,409 10,386 12,125 10,789
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — 4.12% (0.10%)
Cash Flow — 10.54% 57.49%
Earnings — 9.94% (1.56%)
Book Value — (0.55%) (1.53%)

Revenue

Mar Jun Sep Dec Year
’26 4,905 6,379 — — —
’25 4,417 6,456 2,618 3,910 17,401
’24 4,492 6,112 2,326 3,978 16,908
’23 4,884 6,045 2,590 3,707 17,226
’22 4,601 6,252 2,777 3,825 17,455
’21 4,178 5,627 2,371 3,479 15,655
’20 3,956 5,191 1,863 3,207 14,217
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (2,891) (466) — — —
’25 (2,109) 947 193 4,375 3,406
’24 (2,609) 451 130 4,173 2,145
’23 (3,311) 812 (105) 4,373 1,769
’22 (2,730) 1,109 (525) 3,018 872
’21 (1,950) 1,307 (176) 3,546 2,727
’20 (1,930) 1,061 (368) 3,301 2,064
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 (2,972) (587) — — —
’25 (2,195) 846 37 4,181 2,869
’24 (2,752) 352 (42) 3,995 1,553
’23 (3,441) 726 (259) 4,205 1,231
’22 (2,904) 977 (633) 2,900 340
’21 (2,067) 1,181 (293) 3,408 2,229
’20 (2,047) 994 (463) 3,188 1,672
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 1.07 1.73 — — —
’25 0.95 1.92 (0.47) (0.82) 1.60
’24 0.60 1.51 (0.76) (0.06) 1.30
’23 0.83 1.00 (0.45) (0.36) 1.03
’22 0.78 1.33 (0.46) (0.08) 1.58
’21 0.80 1.31 0.04 0.22 2.37
’20 0.36 1.01 (0.52) 0.05 0.91
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1.8
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — 24.10 20.38 36.54 43.74 43.22 44.01 53.40

Analyst estimates 2026–2028

Powerpack
Low Price
— — — 32.78 40.23 49.98 68.43 65.21 64.20 77.41
High Price
— — — — 21,000 21,000 21,000 22,500 22,000 21,500
Employees
0 0 0 0 1 1 1 1 1 1
Revenue/Emp
23,221 10,684 14,287 13,846 14,217 15,655 17,455 17,226 16,908 17,401
Revenue
40.11% 40.81% 30.37% 38.07% 40.16% 41.11% 40.21% 42.41% 43.64% 47.29%
Gross Margin
2,723 (498) (6,806) (316) 675 2,346 1,426 1,093 1,275 1,688
EBT
11.73% (4.66%) (47.64%) (2.28%) 4.75% 14.99% 8.17% 6.35% 7.54% 9.70%
EBT Margin
2,070 2,953 (5,027) (941) 701 1,769 1,158 747 919 1,105
Net Income
1,226 3,208 8,921 2,973 1,177 1,243 1,223 1,211 1,227 1,203
Depreciation
31.00 14.26 19.06 18.47 18.99 21.27 24.22 24.30 24.37 25.59
Revenue/Sh
3.34 3.94 (6.71) (1.28) 0.91 2.39 1.59 1.04 1.31 1.60
Earnings/Sh
4.48 (0.37) 0.64 1.43 2.76 3.71 1.21 2.50 3.09 5.01
Cash Flow/Sh
0.00 1.95 (1.91) (1.22) (0.52) (0.68) (0.74) (0.76) (0.85) (0.79)
Capex/Sh
4.48 1.59 (1.27) 0.21 2.23 3.03 0.47 1.74 2.24 4.22
Free CF/Sh
0.00 0.00 100.28 32.76 33.48 34.82 35.43 35.65 34.64 35.86
Book Value/Sh
749 749 749 750 749 736 721 709 694 680
Shares
120.83 120.83 120.83 0.00 43.02 19.87 37.30 47.15 44.16 42.42
PE Ratio
0.00 0.00 0.00 1.60 2.04 2.22 2.43 2.00 2.34 2.62
PS Ratio
0.29 0.29 0.29 0.90 1.16 1.36 1.66 1.36 1.64 1.87
PB Ratio
0.00 0.00 0.00 1.48 1.85 2.00 2.32 1.98 2.31 2.51
EV/Sales
(9.05) (9.05) (9.05) 131.46 15.73 14.07 119.03 27.76 25.14 15.21
EV/FCF
3,357 (275) 483 1,070 2,064 2,727 872 1,769 2,145 3,406
Op' Cash Flow
(1,019) 1,465 (1,432) (914) (392) (498) (532) (538) (592) (537)
Capex
3,357 1,190 (949) 156 1,672 2,229 340 1,231 1,553 2,869
FCF
— 10,912 9,662 5,281 6,220 5,988 6,051 5,851 4,711 5,210
Working Cap'
— 13,070 7,938 122 1,105 1,117 1,307 2,489 2,703 2,580
Total Debt
— 4,310 5,663 (1,647) (2,690) (3,428) (2,008) (253) (466) (1,950)
Net Debt
— 0 75,153 24,555 25,063 25,623 25,541 25,279 24,030 24,386
Sh' Equity
0.00% 2.63% (9.32%) (1.27%) 1.60% 4.14% 2.70% 1.72% 2.16% 2.62%
ROA
— (1.87%) (5.00%) (0.49%) 2.01% 6.69% 4.00% 3.31% 4.00% 5.20%
ROIC
0.00% 3.91% (6.77%) (1.92%) 2.74% 6.94% 4.48% 2.89% 3.68% 4.52%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Corteva, Inc. peers in Agricultural Inputs

All 18 Agricultural Inputs stocks →

CTVA metrics, ten years each

Corteva, Inc. (CTVA) key facts

  • Corteva, Inc. (CTVA) is an Agricultural Inputs company in the Basic Materials sector, listed on the New York Stock Exchange.
  • Corteva, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 2.92% from fiscal 2024.
  • Net income was $1.1 billion, or $1.60 per share (basic), a net margin of 6.29%.
  • As of September 25, 2026, CTVA traded at $78.52, a market capitalization of $53.0 billion.
  • At that price the stock trades at 52.0× trailing-twelve-month earnings and 2.9× sales.
  • Corteva, Inc. pays an annual dividend of $0.64 per share, a yield of 1.31%, with a payout ratio of 38.2%.
  • Return on equity was 4.52% and debt-to-equity 0.19.

Source: company filings (standardised) and stockrow calculations.

Corteva, Inc. (CTVA) Latest News

News by impact score

Fine-tune

24 Sep

4

INDIANAPOLIS, Sept. 24, 2026 /PRNewswire/ — Corteva (NYSE: CTVA) announced that the U.S. Securities and Exchange Commission has declared Vylor's Registration Statement on Form 10 effective. The Form 10 outlines Vylor’s business, strategy, priorities and the planned separation into an independent, publicly traded company, expected to close on Oct. 1, 2026. Following the separation, Corteva shareholders of record as of the close of business on Sept. 24, 2026 will receive one share of Vylor common stock for each Corteva share held. The distribution is anticipated before 9:30 a.m. ET on Oct. 1, 2026. Vylor will be listed on the NYSE under symbol VYLR beginning Oct. 1, 2026. There will be no when-issued trading in Corteva or ex-distribution trading in Corteva stock. Spin-off creates a major corporate restructuring, altering Corteva's business mix and investor base, with potential material implications for value and capitalization.

21 Sep

3

Vylor, Corteva's planned spin-off on Oct. 1, 2026, and Rainbow Crops, a VIB spin-off, will collaborate to advance gene-edited corn traits using Rainbow Crops' AI-supported Trait Foundry and multiplex editing. The partnership aims to develop hybrids more resilient to heat, drought, and floods, with more efficient inputs and higher yield, validated via high-throughput phenotyping and field trials. Mat Muller will lead Vylor Edge, Vylor's investment platform, which will leverage Rainbow Crops' platform to edit hundreds of genes simultaneously. The collaboration aligns with Europe's June 2026 policy allowing gene-edited plants to be imported and cultivated. Corteva Catalyst-backed Rainbow Crops investment will become part of Vylor Edge after the spin-off. The release contains forward-looking statements and risk disclosures. Spin-off retools Corteva's asset base and shifts biotech exposure via the Rainbow Crops stake into Vylor Edge.

19 Sep

4

Corteva partners with a Belgian firm to advance crop protection initiatives as a core strategic move. Strategic Belgian partnership targets Corteva's core crop protection segment and could meaningfully shift innovation and competitive positioning.

17 Sep

3

Chemours settled PFAS claims for US$455 million, establishing a benchmark that may reduce perceived long-term liability exposure for Corteva. Chemours settlement supplies a valuation reference point for Corteva's own PFAS-related risks.

15 Sep

4

Corteva (CTVA) investors face ongoing fight over Vylor spin-off with key developments to monitor for potential structural changes. Vylor spin-off dispute represents major strategic move likely to alter Corteva trajectory and investor sentiment.

4

Vylor expands soybean leadership with next-gen tech platforms maintaining North America yield advantage and accelerating Latin America lineup through broad spectrum insect control. Next-gen soybean platforms strengthen Corteva competitive edge and market reach in core regions.

4

Corteva's Vylor confirms breakthrough wheat technology launch in 2027. Breakthrough wheat technology launch in 2027 will significantly boost Corteva's competitive position in agricultural markets.

3

Corteva investors should mark September 15 as a key date likely tied to earnings or major company update. September 15 date announcement may affect near-term trading sentiment but does not signal structural change.

14 Sep

4

Corteva board approves spinoff of seed business as Vylor. Seed business spinoff constitutes major strategic restructuring that will alter Corteva operations and market positioning.

3

Corteva board approved Vylor distribution. Board approval of Vylor distribution signals corporate restructuring with moderate effects on operations.

10 Sep

3

Corteva Inc. along with Chemours and DuPont reached an agreement to resolve PFAS-related claims in North Carolina. Agreement resolves PFAS litigation risks for Corteva but likely requires substantial settlement payments affecting near-term finances.

9 Sep

3

Corteva and Globachem signed a definitive agreement to form a joint venture advancing development and commercialization of new formulated crop protection solutions. Joint venture targets core crop protection innovations that could enhance Corteva product pipeline and market position.

3 Sep

3

Vylor launches Vylor Edge, a new investment platform for global agriculture innovation. New platform launch introduces potential moderate effects on Corteva's innovation and market positioning in agriculture.

1 Sep

4

Corteva launches Vylor corn trait with industry-first yield, yield stability, and advanced insect control to drive step-change gains in production and farmer profitability. Vylor launch introduces transformative seed technology that can materially expand Corteva corn market position and revenue.

28 Aug

4

RBC analysts identify Corteva's planned Vylor spin-off as a key catalyst for potential stock rerating. Vylor spin-off constitutes a major strategic move with potential to significantly alter Corteva's trajectory and investor sentiment.

3

Corteva faces near-term headwinds yet its long-term growth outlook holds steady. Near-term obstacles may pressure results while balanced long-term growth prevents major trajectory shift.

24 Aug

3

Corteva faces pricing pressure from Mission Produce with potential offset from higher volumes affecting revenue and margins. Pricing pressure and volume shifts can moderately influence Corteva revenue and margins in the near term.

12 Aug

4

Corteva raised 2026 guidance, shifting investor focus to growth drivers. Higher 2026 guidance signals materially stronger future performance prospects.

7 Aug

4 transcript

Corteva (CTVA) Q2 2026 earnings call transcript covers financial results, operational updates, and management outlook. Earnings call transcripts deliver core financial results and guidance that reshape investor views on performance.

31 Jul

4 transcript

Corteva Inc reported strong first-half performance in its Q2 2026 earnings call and raised full-year guidance. Raised guidance on strong first-half results signals materially higher revenue and earnings trajectory for Corteva.

4

Corteva raises 2026 outlook while split plans remain on schedule. Raised long-term outlook and advancing split represent major strategic developments likely to shift company trajectory and investor views.

4

Seed giant planning Johnston HQ has set date for spinoff from Corteva. Spinoff of major business unit will significantly alter Corteva's corporate structure and financials.

3 transcript

Corteva Q2 earnings call highlighted financial performance, segment results and forward guidance for the agricultural firm. Quarterly earnings and guidance typically produce moderate short-term share-price moves without altering long-term strategy.

3

Corteva Q2 earnings beat estimates while sales missed targets, and the company raised its 2026 outlook. Q2 earnings beat combined with raised 2026 outlook signals moderately positive effects on future expectations.

3 transcript

Corteva reported Q2 2026 results showing revenue growth from seed and crop protection segments, higher EPS, expanded margins, and raised full-year guidance driven by operational efficiencies and favorable demand. Quarterly earnings and guidance updates typically produce moderate effects on near-term stock movement and investor views without fundamentally shifting long-term trajectory.

30 Jul

4

Corteva delivers strong 1H 2026 results, raises FY 2026 outlook, and remains on track for October 1 separation. Strong results plus raised outlook lift financial trajectory while separation advances major restructuring.

3

Corteva reported Q2 earnings with emphasis on key financial metrics including revenue, earnings per share, and segment performance. Quarterly earnings results shape near-term investor sentiment and valuation for the company.

3

Corteva, Inc. (CTVA) reported Q2 earnings that beat estimates. Q2 earnings beat points to stronger financial results likely affecting near-term market sentiment.

29 Jul

3

Corteva shares rallied strongly after beating earnings expectations, leaving investors to assess if the stock is still worth buying. Earnings beat and rally reflect short-term positive results without evidence of major strategic or competitive shifts.

3

Corteva's seed and crop protection businesses serve as primary value drivers for investors through innovation, market share and revenue growth in agriculture. Corteva seed and crop protection segments represent core operations that shape financial performance and competitive positioning.

stockrow.com/CTVA · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com